Ren, K., Zou, L., Yang, B., Jiang, M., Chen, X., Xie, L., Yang, C., Hai, T., Chen, M., Fang, T., Pi, Y. (2025). Glofitamab-based combinatorial therapy demonstrates high efficacy in primary refractory and early relapsed DLBCL: Real-world evidence of durable responses and immune modulation in high-risk subgroups. Blood. https://doi.org/10.1182/blood-2025-7255